Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HuMax-IL8 × Head & Neck × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Dermatologic 2 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Head & Neck 1 Genitourinary 1 Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 550 Radiotherapy 298 pembrolizumab 289 Cetuximab 244 Docetaxel 200 Radiotherapy, Intensity-Modulated 197 Fluorouracil 177 Carboplatin 174 Paclitaxel 148 Nivolumab 127 Gemcitabine 113 Radiation 82 Magnetic Resonance Spectroscopy 81 Drug Therapy 75 toripalimab 68 Capecitabine 67 Surveys and Questionnaires 64 Surgical Procedures, Operative 62 Biopsy 58 durvalumab 55 Blood Specimen Collection 48 Cyclophosphamide 43 Chemoradiotherapy 43 camrelizumab 41 Standard of Care 39 Specimen Handling 39 Erlotinib Hydrochloride 38 Bevacizumab 38 tislelizumab 37 Radiosurgery 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04848116 2025-12-18

Spark2

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡